HomeCompareESRX vs XYLD

ESRX vs XYLD: Dividend Comparison 2026

ESRX yields 2.17% · XYLD yields 11.20%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 XYLD wins by $3.0K in total portfolio value· pulled ahead in Year 5
10 years
ESRX
ESRX
● Live price
2.17%
Share price
$92.33
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.9K
Annual income
$249.17
Full ESRX calculator →
XYLD
Global X S&P 500 Covered Call ETF
● Live price
11.20%
Share price
$38.36
Annual div
$4.30
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.9K
Annual income
$3,351.03
Full XYLD calculator →

Portfolio growth — ESRX vs XYLD

📍 XYLD pulled ahead of the other in Year 5

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodESRXXYLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ESRX + XYLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ESRX pays
XYLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ESRX
Annual income on $10K today (after 15% tax)
$184.12/yr
After 10yr DRIP, annual income (after tax)
$211.79/yr
XYLD
Annual income on $10K today (after 15% tax)
$952.37/yr
After 10yr DRIP, annual income (after tax)
$2,848.38/yr
At 15% tax rate, XYLD beats the other by $2,636.58/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ESRX + XYLD for your $10,000?

ESRX: 50%XYLD: 50%
100% XYLD50/50100% ESRX
Portfolio after 10yr
$24.4K
Annual income
$1,800.09/yr
Blended yield
7.39%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ESRX buys
0
XYLD buys
0
No recent congressional trades found for ESRX or XYLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricESRXXYLD
Forward yield2.17%11.20%
Annual dividend / share$2.00$4.30
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$22.9K$25.9K
Annual income after 10y$249.17$3,351.03
Total dividends collected$2.3K$20.2K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: ESRX vs XYLD ($10,000, DRIP)

YearESRX PortfolioESRX Income/yrXYLD PortfolioXYLD Income/yrGap
1$10,917$216.61$10,840$1,120.44+$77.00ESRX
2$11,902$221.00$11,786$1,249.59+$116.00ESRX
3$12,960$225.18$12,854$1,397.78+$106.00ESRX
4$14,096$229.16$14,063$1,568.33+$33.00ESRX
5← crossover$15,316$232.95$15,434$1,765.19$118.00XYLD
6$16,625$236.55$16,995$1,993.14$370.00XYLD
7$18,029$239.96$18,777$2,257.95$748.00XYLD
8$19,534$243.20$20,818$2,566.58$1.3KXYLD
9$21,147$246.26$23,163$2,927.50$2.0KXYLD
10$22,877$249.17$25,865$3,351.03$3.0KXYLD

ESRX vs XYLD: Complete Analysis 2026

ESRXStock

Express Scripts is a pharmacy benefit management (PBM) organization founded in 1986. It offers integrated services like pharmacy claims processing, home delivery, formulary management, specialty pharmacy via Accredo, and data-driven drug utilization insights. The company is a subsidiary of Cigna following a $54 billion acquisition completed in December 2018.

Full ESRX Calculator →

XYLDETF

The Global X S&P 500 Covered Call ETF (XYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe S&P 500 BuyWrite Index.

Full XYLD Calculator →
📬

Get this ESRX vs XYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ESRX vs SCHDESRX vs JEPIESRX vs OESRX vs KOESRX vs MAINESRX vs QYLDESRX vs JEPQESRX vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.